These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1719676)

  • 1. cGMP: the wayward child of the cyclic nucleotide family.
    Goy MF
    Trends Neurosci; 1991 Jul; 14(7):293-9. PubMed ID: 1719676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic GMP as a second messenger in the cardiovascular system.
    Imai S
    Jpn Heart J; 1995 Mar; 36(2):127-77. PubMed ID: 7596037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization of NO/cGMP signaling in smooth muscle: blood vessels versus airways.
    Mullershausen F; Lange A; Mergia E; Friebe A; Koesling D
    Mol Pharmacol; 2006 Jun; 69(6):1969-74. PubMed ID: 16510560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of rabbit ventricular cell volume and Na+/K+/2Cl- cotransport by cGMP and atrial natriuretic factor.
    Clemo HF; Feher JJ; Baumgarten CM
    J Gen Physiol; 1992 Jul; 100(1):89-114. PubMed ID: 1355106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cGMP metabolism in frog rods.
    Kawamura S; Murakami M
    Neurosci Res Suppl; 1990; 12():S175-81. PubMed ID: 1978746
    [No Abstract]   [Full Text] [Related]  

  • 6. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
    Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic GMP in cell function.
    Tremblay J; Gerzer R; Hamet P
    Adv Second Messenger Phosphoprotein Res; 1988; 22():319-83. PubMed ID: 2906250
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
    Murad F; Waldman S; Molina C; Bennett B; Leitman D
    Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
    Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
    Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
    Greenberg SS; Cantor E; Ho E; Walega M
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function.
    Hamad AM; Clayton A; Islam B; Knox AJ
    Am J Physiol Lung Cell Mol Physiol; 2003 Nov; 285(5):L973-83. PubMed ID: 14551038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide-evoked transient kinetics of cyclic GMP in vascular smooth muscle cells.
    Cawley SM; Sawyer CL; Brunelle KF; van der Vliet A; Dostmann WR
    Cell Signal; 2007 May; 19(5):1023-33. PubMed ID: 17207606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New type of receptor found.
    Marx JL
    Science; 1989 Jun; 244(4909):1140-1. PubMed ID: 2567057
    [No Abstract]   [Full Text] [Related]  

  • 14. P2Y(1) and P2Y(2) receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed.
    Buvinic S; Briones R; Huidobro-Toro JP
    Br J Pharmacol; 2002 Jul; 136(6):847-56. PubMed ID: 12110609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic GMP systems in the retina.
    Ferrendelli JA; De Vries GW
    Fed Proc; 1983 Nov; 42(14):3103-6. PubMed ID: 6138283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic GMP phosphodiesterases and regulation of smooth muscle function.
    Rybalkin SD; Yan C; Bornfeldt KE; Beavo JA
    Circ Res; 2003 Aug; 93(4):280-91. PubMed ID: 12933699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.
    Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA
    Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulation and physiological roles of the guanylyl cyclase receptors.
    Tamura N; Chrisman TD; Garbers DL
    Endocr J; 2001 Dec; 48(6):611-34. PubMed ID: 11873860
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo reconstitution of the negative feedback in nitric oxide/cGMP signaling: role of phosphodiesterase type 5 phosphorylation.
    Mullershausen F; Russwurm M; Koesling D; Friebe A
    Mol Biol Cell; 2004 Sep; 15(9):4023-30. PubMed ID: 15240816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.